[Methyl-ter-butyl ether (MTBE) therapy of cholesterol biliary calculosis. First long-term controls (up to 22 months)].
The results and clinical and instrumental examinations of 12 patients at least 6 months after MTBE treatment for cholesterine biliary calculosis are presented. No recurrence of stones or alterations to the biliary ways or duodenal mucosa attributable to MTBE were encountered.
Gabasio
S
S
Divisione di Medicina Interna, Ospedale Gradenigo, Torino.
Bonardi
L
L
Colombo
G
G
Juliani
E
E
Leone
A
A
Gandini
G
G
D000328:Adult; D000368:Aged; D001649:Bile Duct Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy; D002769:Cholelithiasis / Q000032:analysis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002784:Cholesterol / Q000032:analysis; D004987:Ethers / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008738:Methyl Ethers; D008875:Middle Aged; D011859:Radiography
D004987:Ethers; D008738:Methyl Ethers; C043243:methyl tert-butyl ether; D002784:Cholesterol
Trattamento con metil-ter-butil etere (MTBE) della calcolosi biliare colesterinica. Primi controlli a distanza (fino a 22 mesi).